Direct unimolar one-step valeroylation of methyl α-
d
-mannopyranoside (MDM) furnished mainly 6-
O
-valeroate. However, similar reaction catalyzed by DMAP resulted 3,6-di-
O
-valeroate (21%) and 6-
O
-valeroate (47%) indicating reactivity sequence as 6-OH>3-OH>2-OH,4-OH. To get potential antimicrobial agents, 6-
O
-valeroate was converted into four 2,3,4-di-
O
-acyl esters, and 3,6-di-
O
-valeroate was converted into 2,4-di-
O
-acetate. Direct tetra-
O
-valeroylation of MDM gave a mixture of 2,3,4,6-tetra-
O
-valeroate and 2,3,6-tri-
O
-valeroate indicating that the C2–OH is more reactive than the equatorial C4–OH. The activity spectra analysis along with
in vitro
antimicrobial evaluation clearly indicated that these novel MDM esters had better antifungal activities over antibacterial agents. In this connection, molecular docking indicated that these MDM esters acted as competitive inhibitors of sterol 14α-demethylase (CYP51), an essential enzyme for clinical target to cure several infectious diseases. Furthermore, pharmacokinetic studies revealed that these MDM esters may be worth considering as potent candidates for oral and topical administration. Structure activity relationship (SAR) affirmed that saturated valeric chain (C5) in combination with caprylic (C8) chains was more promising CYP51 inhibitor over conventional antifungal antibiotics.